Preventive role of PD-1 on MPTP-induced dopamine depletion in mice

Cell Biochemistry and Function

Volumn 28, Issue 3, 2010, Pages 217-223

  Jung, Hyo Won ^a   Son, Hye Young ^b   Jin, Guang Zhen ^b   Park, Yong Ki ^a,b  

^a Dongguk University   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

MPTP; Neuroprotection; Parkinson's disease; PD 1; Traditional Korean medicine; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIPARKINSON AGENT; BCL2 RELATED PROTEIN A1; BOMBYX MORI EXTRACT; CASPASE 3; CHAENOMELES SINENSIS EXTRACT; CINNAMOMUM CASSIA EXTRACT; CYTOCHROME C; DOPAMINE; GINGER EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; HERBACEOUS AGENT; LIRIOPE PLATYPHYLLA EXTRACT; PAEONIA LACTIFLORA EXTRACT; PD 1; PHYLLOSTACHYS NIGRA EXTRACT; PLANT EXTRACT; PROTEIN BAX; PUERARIA THUNBERGIANA EXTRACT; SAPOSHNIKOVIA DIVARICATA EXTRACT; TRICHOSANTHES KIRILOWII EXTRACT; TYROSINE 3 MONOOXYGENASE; UNCARIA SINENSIS EXTRACT; UNCLASSIFIED DRUG; ZIZYPHUS JUJUBE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOSOL; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME RELEASE; FRUIT; KOREAN MEDICINE; MALE; MEDICINAL PLANT; MITOCHONDRION; MOUSE; NERVE CELL NECROSIS; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PLANT ROOT; PLANT STEM; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; CORPUS STRIATUM; DOPAMINE; HUMANS; KOREA; MEDICINE, KOREAN TRADITIONAL; MICE; MICE, INBRED C57BL; MPTP POISONING; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PLANT PREPARATIONS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 77953592694     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1642     Document Type: Article

References (36)

1. Marsden CD. Parkinson's disease. Lancet 1990; 335: 948-952.
2. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219: 979-980.
3. Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1- methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 1984; 224: 1451-1453.
4. Bonifati V, Rizzu P, Squitieri F, et al. DJ-1(PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 2003; 24: 159-160. (Pubitemid 37304291)
5. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-259. (Pubitemid 36131051)
6. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004; 304: 1158-1160.
7. Mizuno Y, Saitoh T, Sone N. Inhibition of mitochondrial NADHubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun 1987; 143: 294-299. (Pubitemid 17030496)
8. O'Byrne MB, Bolam JP, Hanley JJ, Tipton KF. Tyrosine-hydroxylase immunoreactive cells in the rat striatum following treatment with MPP+. Adv Exp Med Biol 2000; 483: 369-374.
9. Pettmann B, Henderson CE. Neuronal cell death. Neuron 1998; 20: 633-647.
10. O'Brien NM, Woods JA, Aherne SA, O'Callaghan YC. Cytotoxicity, genotoxicity and oxidative reactions in cell-culture models: modulatory effects of phytochemicals. Biochem Soc Trans 2000; 28: 22-26.
11. Slater AF, Nobel CS, Orrenius S. The role of intracellular oxidants in apoptosis. Biochim Biophys Acta 1995; 1271: 59-62.
12. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
13. Van Kampen J, Robertson H, Hagg T, Drobitch R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp Neurol 2003; 184: 521-529.
14. Li Q, Zhao D, Bezard E. Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature. Behav Pharmacol 2006; 17: 403-410.
15. Sakai R, Irie Y, Murata T, Ishige A, Anjiki N, Watanabe K. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice. Phytother Res 2007; 21: 868-873.
16. Liu B, Xie JX, Tsang LL, et al. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity. Cell Biol Int 2008; 32: 86-92.
17. Sugawara T, Noshita N, Lewén A, et al. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemia damage by blocking the mitochondrial pathway of caspase activation. J Neurosci 2002; 22: 209-217.
18. Sadoul R. Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ 1998; 5: 805-815.
19. Cheng XX, Li FQ, Huang M, Wang XM, Han JS. Protective effect of tripchlorolide on dopaminergic neurons in partially lesioned rat model of Parkinson's disease. Yao Xue Xue Bao 2002; 37: 339-342.
20. Liu HQ, Zhang WY, Luo XT, Ye Y, Zhu XZ. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br J Pharmacol 2006; 148: 314-325.
21. Blanchet J, Longpré F, Bureau G, et al. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1243-1250.
22. Geng X, Tian X, Tu P, Pu X. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. Eur J Pharmacol 2007; 564: 66-74. (Pubitemid 46946841)
23. Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced Parkinsonism in mice: role of oxidative stress. Eur J Neurosci 2008; 28: 41-50.
24. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369-377.
25. Cassarino DS, Parks JK, Parker WD, Jr, Bennett JP, Jr. The parkinsonian neurotoxin MPP opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1999; 1453: 49-62.
26. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 1996; 271: 4573-4576.
27. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
28. Shimada Y, Goto H, Kogure T, et al. Extract prepared from the bark of Cinnamomum cassia Blume prevents glutamate-induced neuronal death in cultured cerebellar granule cells. Phytother Res 2000; 14: 466-468.
29. Shimada Y, Goto H, Kogure T, et al. Protective effect of phenolic compounds isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death. Am J Chin Med 2001; 29: 173-180.
30. Cui YM, Ao MZ, Li W, Yu LJ. Effect of glabridin from Glycyrrhiza glabra on learning and memory in mice. Planta Med 2008; 74: 377-380.
31. Yu XQ, Xue CC, Zhou ZW, et al. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci 2008; 82: 68-78.
32. Kabuto H, Nishizawa M, Tada M, Higashio C, Shishibori T, Kohno M. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6- hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem Res 2005; 30: 325-332.
33. Zhang HY, Liu YH, Wang HQ, Xu JH, Hu HT. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol Int 2008; 32: 1230-1237.
34. Olden K, Guthrie J, Lawler C. Partnership for Parkinson's disease research: patient-researcher-clinician-sponsor. Neurotoxicology 2002; 23: 451-456.
35. Aruoma OI, Bahorun T, Jen LS. Neuroprotection by bioactive components in medicinal and food plant extracts. Mutat Res 2003; 544: 203-215.
36. Chung V, Liu L, Bian Z, et al. Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review. Mov Disord 2006; 21: 1709-1715.